Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA
Authors
Keywords
Basal insulin, IBM Explorys database, Real-world evidence, Type 2 diabetes
Journal
Diabetes Therapy
Volume 9, Issue 3, Pages 1347-1358
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1007/s13300-018-0413-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis
- (2017) Xiaoling Cai et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clinical inertia to insulin initiation and intensification in the UK: A focused literature review
- (2017) Kamlesh Khunti et al. Primary Care Diabetes
- Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
- (2017) Virginia Valentine et al. Diabetes Therapy
- Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
- (2017) Virginia Valentine et al. Diabetes Therapy
- Deaths Attributable to Diabetes in the United States: Comparison of Data Sources and Estimation Approaches
- (2017) Andrew Stokes et al. PLoS One
- Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs
- (2016) Philip Levin et al. CLINICAL THERAPEUTICS
- Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
- (2016) K. Khunti et al. DIABETES OBESITY & METABOLISM
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM –2016 EXECUTIVE SUMMARY
- (2016) Alan J. Garber et al. Endocrine Practice
- Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
- (2015) Sanjoy K Paul et al. Cardiovascular Diabetology
- Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes
- (2015) Shi-Dou Lin et al. Primary Care Diabetes
- Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study
- (2014) W. H. Polonsky et al. DIABETES OBESITY & METABOLISM
- Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus
- (2014) W.D. Strain et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Assessing achievement and maintenance of glycemic control by patients initiating basal insulin
- (2012) Ning Wu et al. CURRENT MEDICAL RESEARCH AND OPINION
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Proportion of patients at HbA1c target
- (2011) K. Esposito et al. DIABETES OBESITY & METABOLISM
- Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes
- (2010) Edith M. Heintjes et al. ADVANCES IN THERAPY
- A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
- (2010) J. Gordon et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Insulin Therapy and Type 2 Diabetes: Management of Weight Gain
- (2009) Samy I. McFarlane Journal of Clinical Hypertension
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started